v3.25.4
STOCKHOLDERS’ EQUITY
 3 Months Ended
Dec. 31, 2025
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY

 

Common Stock

 

As of December 31, 2025, and September 30, 2025, we had 4,446,713 shares of common stock outstanding. The outstanding shares were retroactively restated for the effect of the Reverse Split from 231,229,054 to 4,446,713.

 

The authorized shares and par value per share of common stock were unchanged by the Reverse Split and remain at 681,000,000 shares and $0.001 per share, respectively.

 

We restated our common shares outstanding (shares and amount) and the value of our APIC to reflect the number of shares outstanding after the Reverse Split.

 

Preferred Stock

 

As of December 31, 2025, we had zero (0) shares of preferred stock outstanding and were authorized to issue 10,000,000 shares of preferred stock at a par value of $0.001 per share.

 

 

Warrants

 

We have four categories of warrants outstanding which are summarized below along with exercise prices and expiration dates.

 

(In thousands, except prices and lives) 

Number of

Warrants

   Exercise Price   Expiration Date
2018 Placement Agent   106  $52.00   Aug 7, 2028
2021 Private Placement   231   18.72   Apr 16, 2026
2021 Placement Agent   160   9.36   Apr 16, 2031
2023 Warrant Exchange   335   9.36   Dec 29, 2028
Total Outstanding Warrants   832        

 

The following table summarizes warrant activity for the three months ended December 31, 2025:

 

(In thousands, except prices and lives) 

Number of

Warrants

  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining Life

 
Outstanding at September 30, 2025   832  $17.40   2.89 
Granted   —    —    — 
Exercised   —    —    — 
Canceled/Forfeited   —    —    — 
Outstanding at December 31, 2025   832  $17.40   2.64